Taylor J M, Macklem M M, Parsons J T
Department of Microbiology, Health Sciences Center, University of Virginia, Charlottesville, Virginia, USA.
J Cell Sci. 1999 Jan;112 ( Pt 2):231-42. doi: 10.1242/jcs.112.2.231.
Graf, the GTPase regulator associated with focal adhesion kinase was previously shown to have GAP activity for &Rgr; A and Cdc42 in vitro (Hildebrand et al 1996 Mol. Cell Biol. 16: 3169-3178). In this study we sought to determine whether Graf acted at the level of Cdc42, Rho, or both in vivo and whether Graf was a signal terminator or transducer for these proteins. Microinjection of Graf cDNA into subconfluent Swiss 3T3 cells (in the presence of serum) has marked effects on cell shape and actin localization. Graf expression causes clearing of stress fibers followed by formation of long actin based filopodial-like extensions. Similar phenotypes were observed following injection of the Rho-inhibitor, C3 into these cells. The Graf response was dependent on GAP activity, since injection of Graf cDNA containing point mutations in the GAP domain (R236Q or N351V) which block enzymatic activity, does not confer this phenotype. Injection of Graf into Swiss 3T3 cells in which Rho has been down-regulated by serum starvation has no effect on cell morphology. Using this system, we demonstrate that Graf blocks sphingosine-1-phosphate (SPP) stimulated (Rho-mediated) stress fiber formation. Conversely, Graf expression does not inhibit bradykinin stimulated (Cdc42-mediated) filopodial extensions. These data indicate that Graf is a GAP for Rho in vivo. To further substantiate these results we examined the effect of Graf over-expression on Rho-mediated neurite retraction in nerve growth factor (NGF)-differentiated PC12 cells. In PC12 cells, which express relatively high levels of endogenous Graf, overexpression of Graf (but not Graf containing the R236Q mutation) enhances SPP-induced neurite retraction. These data indicate the possibility that Graf may be an effector for Rho in certain cell types.
与粘着斑激酶相关的GTP酶调节蛋白Graf先前已被证明在体外对Rho A和Cdc42具有GAP活性(希尔德布兰德等人,1996年,《分子细胞生物学》16: 3169 - 3178)。在本研究中,我们试图确定Graf在体内是作用于Cdc42、Rho水平,还是两者都起作用,以及Graf是这些蛋白的信号终止子还是转导子。将Graf cDNA显微注射到亚汇合的瑞士3T3细胞(在有血清的情况下)对细胞形态和肌动蛋白定位有显著影响。Graf表达导致应力纤维消失,随后形成基于肌动蛋白的长丝状伪足样延伸。向这些细胞中注射Rho抑制剂C3后也观察到了类似的表型。Graf反应依赖于GAP活性,因为注射在GAP结构域含有点突变(R236Q或N351V)从而阻断酶活性的Graf cDNA不会赋予这种表型。将Graf注射到通过血清饥饿使Rho下调的瑞士3T3细胞中对细胞形态没有影响。利用这个系统,我们证明Graf阻断了1 - 磷酸鞘氨醇(SPP)刺激的(Rho介导的)应力纤维形成。相反地, Graf表达并不抑制缓激肽刺激的(Cdc42介导的)丝状伪足延伸。这些数据表明Graf在体内是Rho的GAP。为了进一步证实这些结果,我们研究了Graf过表达对神经生长因子(NGF)分化的PC12细胞中Rho介导的神经突回缩的影响。在表达相对高水平内源性Graf的PC12细胞中,Graf(但不包括含有R236Q突变的Graf)的过表达增强了SPP诱导的神经突回缩。这些数据表明Graf在某些细胞类型中可能是Rho的效应器。